Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Zoledronic Acid Plus Teriparatide	137
Overall Study	STARTED	Zoledronic Acid	137
Overall Study	STARTED	Placebo Zoledronic Acid Plus Teriparatide	138
Overall Study	Safety Population	Zoledronic Acid Plus Teriparatide	137
Overall Study	Safety Population	Zoledronic Acid	137
Overall Study	Safety Population	Placebo Zoledronic Acid Plus Teriparatide	137
Overall Study	COMPLETED	Zoledronic Acid Plus Teriparatide	126
Overall Study	COMPLETED	Zoledronic Acid	131
Overall Study	COMPLETED	Placebo Zoledronic Acid Plus Teriparatide	131
Overall Study	NOT COMPLETED	Zoledronic Acid Plus Teriparatide	11
Overall Study	NOT COMPLETED	Zoledronic Acid	6
Overall Study	NOT COMPLETED	Placebo Zoledronic Acid Plus Teriparatide	7

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00439244/flow